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Minimal deviation adenocarcinoma (MDA) of the uterine cervix is a rare disease. The rate of misdiagnosis
is relatively high and there is no standard treatment. A 58-year-old woman presented with an abnormal
Pap smear revealing atypical glandular cells and vaginal mucoid discharge. Cervical biopsy revealed
cervicitis and an endometrium with atypical glands and increasing mitoses. A frozen section of curetted
endometrial tissue revealed adenocarcinoma. Surgical staging with laparoscopic hysterectomy, bilateral
salpingo-oophorectomy, and bilateral pelvic lymph node dissection was then performed. However,
uterine cervical MDA was conﬁrmed by pathology and immunohistochemistry with carcinoembryonic
antigen and vimentin. Because the staging surgery was inadequate (the parametrium was not radically
resected), postoperative adjuvant therapy with concurrent chemoradiation was performed. The patient
remained disease-free as of the last follow-up 6 months postoperatively. MDA is difﬁcult to diagnose and
depends on its clinical manifestations and pathologic features. Surgery with adjuvant chemo-
radiotherapy achieves good outcomes.
Copyright © 2014, Buddhist Compassion Relief Tzu Chi Foundation. Published by Elsevier Taiwan LLC.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).1. Introduction
Minimal deviation adenocarcinoma of the uterine cervix (MDA)
is a rare variant of cervical cancer. Originally designated “malignant
adenoma of the cervix” by Gusserrow, MDA accounts for 1e3% of all
cervical cancers [1]. Because of its benign microscopic appearance,
the term “minimal deviation adenocarcinoma” has been proposed
for this tumor [2].
This case of MDA in a 58-year-old woman demonstrates the
disease characteristics, diagnostic challenge, and therapeutic stra-
tegies that distinguish it from endometrioid adenocarcinoma.
2. Case report
A 58-year-old, multiparous woman (gravida 5, para 3, with 2
abortions) presented in 2009 with an abnormal Pap smear, whichnd Gynecology, Buddhist Tzu
ng Road, Hualien, Taiwan.
g).
lief Tzu Chi Foundation. Publishedrevealed atypical glandular cells. Previous Pap smears in 2003,
2007, and 2008 had yielded unremarkable results. She had meno-
pause at the age of 48 years and had taken hormone therapy for 13
years. She often complained of itching of the vulva and mucoid
vaginal discharge, but denied any postmenopausal bleeding. Col-
poscopy revealed an unsatisfactory transformation zone, small
protruding lump in the endocervix. A cervical biopsy and endo-
cervical curettage revealed chronic cervicitis.
A Pap smear in 2013 revealed atypical glandular cells, which
favored a neoplasm. A colposcopy 1 month later revealed acetow-
hite epithelium over a large area of the cervix, involving the vaginal
fornix and upper vagina. The level of the tumor marker squamous
cell carcinoma antigen was 0.9 ng/mL (normal range <1.5 ng/mL.
The human papillomavirus titer was 0.19. There were no vessel
changes. Pelvic ultrasonography revealed an intrauterine
33 mm  16 mm  31 mm hypoechoic lesion with an echogenic
ring. A cervical biopsy showed cervicitis. Diagnostic dilation and
curettage (D&C) showed atypical glands with stratiﬁed nuclei and
increased mitosis.
The patient received oral progesterone therapy for 1 month.
However, therewas no regression of the endometrial lesion and she
was admitted for surgical intervention. A D&C was performed ﬁrstby Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license
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noma. Two months later, laparoscopic staging surgery was per-
formed, including a hysterectomy, bilateral salpingo-
oophorectomy, and bilateral pelvic lymph node dissection.
Grossly, the cervix was thickened and hard, without other macro-
scopic ﬁndings (Fig. 1A). The microscopic examination revealed
cervical mucilaginous glands that were irregular in size and shape
with increased apophysis. The glands typically exhibited deep in-
vasion of the cervical wall adjacent to the cervical adventitia
(Fig. 1B). The cervical tumor was 1.0 cm  1.0 cm  0.6 cm with
stromal invasion of 6 mm. No vascular invasion or lymphatic
spreading was noted. Immunohistochemistry of the cervical tumor
was positive for carcinoembryonic antigen (Fig. 1C) and vimentin
(Fig. 1D). The pelvic lymph nodes showed no evidence of malig-
nancy. Postoperative computer tomography revealed no
lymphadenopathy.
The tumor was staged as Ib MDA of the cervix according to the
International Federation of Gynecology and Obstetrics classiﬁca-
tion. Due to incidentally found cervical cancer with inadequate
staging surgery, concurrent chemoradiotherapy was performed
subsequently and ﬁnished two months postoperatively. The value
of the tumor marker CA125 remained within the normal range
(<35 IU/mL during follow-up. The patient was disease-free on the
last follow-up, 6 months postoperatively.
3. Discussion
A review article reported that half of nearly 60 patients with
MDA presented with vaginal bleeding and discharge [3]. Surgical
resection was the mainstay of treatment.
MDA may originate from gastric metaplasia or PeutzeJeghers
syndrome [4]. Humanpapillomavirus rarely presents inMDA [5e7].
The symptoms and signs are not different from those of common
cervical adenocarcinoma. In this case, the patient presented withFig. 1. Gross and histologic characteristics of minimal deviation adenocarcinoma of the cerv
tubules. Papillary folding and irregular branching lined by mildly atypical cells. Distinct nu
staining). Immunohistochemistry of the minimal deviation adenocarcinoma was positive fomucoid vaginal discharge. Cytologic examination and punch biopsy
failed to conﬁrm a diagnosis of MDA and the confusing diagnosis of
endometrial cancer led to staging surgery. The diagnosis of MDA
was based on histopathology. Previous studies have demonstrated
that cytologic examination of the cervix for MDA is insufﬁcient.
However, a biopsy of the cervix and cervical canal, and conization of
the cervix can lead to a deﬁnite diagnosis of MDA [8]. Nevertheless,
cervical biopsy and endocervical curettage failed to prove the cor-
rect diagnosis in this case. Pathological examination of tissue
retrieved by D&C could only prove adenocarcinoma. Our experi-
ence shows the difﬁculties in this clinical scenario.
Magnetic resonance imaging and ultrasonography are inade-
quate for diagnosing MDA because of the benign appearance of the
mass. Nonetheless, both imaging techniques play important roles
in evaluating the dissemination of disease [9]. They may reveal
intrauterine ﬂuid accumulation and multiple, irregular cystic le-
sions that present as low-signals on T1-weighted imaging, and as
high-signals on T2-weighted imaging [10].
MDA exhibits a diffusely inﬁltrative growth pattern and its
histologic differentiation from normal cervical glands is chal-
lenging [11]. Histologically, MDA is characterized by a hazardous
arrangement of endocervical glands and their deep penetration
into the cervical wall, with minor cytological atypia. Immunohis-
tochemistry can assist in the differential diagnosis of MDA. Carci-
noembryonic antigen, Ki67, Alcian blue-periodic acid-Schiff
staining, and p53 can be used for diagnosis of MDA [12]. Vimentin is
also positive in tumor stroma and can be used for the diagnosis
[12].
Currently, surgery remains the mainstay treatment for MDA. In
previous reports, patients with early stage MDA treated with
radical hysterectomy and pelvic lymph node dissection along with
postoperative chemotherapy or radiotherapy showed no tumor
recurrence [13e15]. However, postoperative adjuvant therapy may
be required in the late stage of the disease. In the present case,ix. (A) Gross picture of the uterus and cervix. (B) Mucinous glands exhibiting abnormal
clear anaplasia and stromal invasion were also noted (100; H&E, hematoxylineeosin
r (C) carcinoembryonic antigen (CEA) and (D) vimentin (100 and 400, respectively).
D.-C. Ding et al. / Tzu Chi Medical Journal 28 (2016) 79e81 81concurrent chemoradiation was performed because of inadequate
staging surgery. However, because of small case numbers, the
deﬁnite treatment and prognosis have not been determined. We
will continue to follow-up this patient to ensure that the adjuvant
chemoradiation was effective.
In conclusion, early diagnosis followed by appropriate evalua-
tion and treatment of MDA is a challenge for gynecologists. Surgical
management with radical hysterectomy might be the choice of
treatment, but postoperative adjuvant therapy might be necessary,
especially in the late stage of the disease. Clinical difﬁculties can be
encountered, as in this case. Evaluation of more cases to establish
clear diagnosis and treatment guidelines is imperative.
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